Alzheimer's Disease (AD) is the most common subtype of dementia. As the prevalence of dementia is projected to increase, the burden of the disease on society is expected to become increasingly significant. The link between eye pathology and neurodegenerative diseases has been established in multiple studies. In particular, optic nerve parameters associated with neuronal loss in AD include retinal ganglion cells (RGC). Retinal ganglion cells are similar to neurons in the cerebral cortex, and have been correlated to neurodegeneration in AD. Ocular imaging techniques such as optical coherence tomography (OCT) have provided a rapid and non-invasive method for quantifying optic nerve parameters in vivo. Spectral domain (SD)-OCT has shown good potential in the study of the optic nerve in AD as it enables more comprehensive assessment of RGCs. Earlier generation OCT techniques only assess the retinal nerve fibre layer, which consists of RGC axons. Spectral domain-OCT offers ultra-high scan speed and image resolution, enabling improved sampling of retinal layers. Retinal layers such as the ganglion cell-inner plexiform layer (GC-IPL), which contain the dendrites and nuclei of RGCs, can be assessed with SD-OCT. This article presents a review of literature associating eye pathology with AD, and explores the potential of SD-OCT in future AD studies. Spectral domain-OCT has the potential to draw more links between optic nerve pathology and neurodegeneration.
LimHJ.LimJPAnthonyPYeoDHSahadevanS. Prevalence of cognitive impairment amongst Singapore's elderly Chinese: A community-based study using the ECAQ and the IQCODE. Int J Geriatr Psychiatry2003;18(2):142–8 doi: 10.1002/gps.803.
3.
Ministry of Community Development, Youth and Sports (SG). Inter-Ministerial Committee (IMC) report on the ageing population. Singapore; 1999. 188 p.
4.
Access Economics for Asia Pacific Members of Alzheimer's Disease International. Dementia in the Asia Pacific region: Statistical appendix. Alzheimer's Disease International; 2006. 33 p.
5.
BrunnstromHGustafsonLPassantUEnglundE. Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reports. Arch Gerontol Geriatr2009;49(1):146–9 doi: 10.1016/j.archger.2008.06.005.
6.
O'BrienJT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol2007;80(2 Spec No):S71–7 doi: 10.1259/bjr/33117326.
7.
PattonNAslamTMacGillivrayTPattieADearyIJDhillonB. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: A rationale based on homology between cerebral and retinal microvasculatures. J Anat2005;206(4):319–48 doi: 10.111/j.1469–7580.2005.00395.x.
8.
LondonABenharISchwartzM. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol2013;9(1):44–53 doi: 10.1038/nrneurol.2012.227.
9.
LesageSRMosleyTHWongTYSzkloMKnopmanDCatellierDJ. Retinal microvascular abnormalities and cognitive decline: The ARIC 14-year follow-up study. Neurology2009;73(11):862–8 doi: 10.1212/WNL.0b013e3181b78436.
10.
WongTYKleinRSharrettARNietoFJBolandLLCouperDJ. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: The Atherosclerosis Risk in Communities Study. Stroke2002;33(6):1487–92 doi: 10.1161/oi.STR.0000016789.56668.43.
11.
HintonDRSadunAABlanksJCMillerCA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med1986;315(8):485–7 doi: 10.1056/nejm198608213150804.
12.
BlanksJCTorigoeYHintonDRBlanksRH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging1996;17(3):377–84 doi: 10.1016/0197-4580(96)00010-3.
13.
BlanksJCSchmidtSYTorigoeYPorrelloKVHintonDRBlanksRH. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging1996;17(3):385–95 doi: 10.1016/0197-4580(96)00009-7.
14.
BerishaFFekeGTTrempeCLMcMeelJWSchepensCL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci2007;48(5):2285–9 doi: 10.1167/iovs.06–1029.
15.
ParisiVRestuciaRFattappostaFMinaCBucciMGPierelliF. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol2001;112(10):1860–7 doi: 10.1016/s1388-2457(01)00620-4.
16.
KalesnykasGTuulosTUusitaloHJolkkonenJ. Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models. Neuroscience2008;155(3):937–47 doi: 10.1016/j.neuroscience.2008.06.038.
GhezziAMartinelliVTorriVZaffaroniMRodegherMComiG. Long-term follow-up of isolated optic neuritis: The risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol1999;246(9):770–5 doi: 10.1007/s004150050453.
19.
ArchibaldNKClarkeMPMosimannUPBurnDJ. The retina in Parkinson's disease. Brain2009;132(5):1128–45 doi: 10.1093/brain/awp068.
20.
DevosDTirMMaurageCAWaucquierNDefebvreLDefoort-ShellemmesS. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology2005;65(7):1107–10 doi: 10.1212/01.wnl.0000178896.44905.33.
21.
MoschosMMTagarisGMarkopoulosIMargetisITsapakisSKanakisM. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol2011;21(1):24–9 doi: 10.5301/ejo.2010.1318.
AltintasOIseriPOzkanBCaglarY. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol2008;116(2):137–46 doi: 10.1007/s10633-007-9091-8.
24.
ArmstrongRASyedAB. Alzheimer's disease and the eye. Ophthalmic Physiol Opt1996;16(Suppl 1):S2–8 doi: 10.1111/j.1475-1313.1996.95001344.x.
25.
WenkGL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry2003;64(Suppl 9):7–10.
RogersJMorrisonJH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci1985;5(10):2801–8.
28.
BrunAEnglundE. Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histopathological grading. Histopathology1981;5(5):549–64.
29.
LewisDACampbellMJTerryRDMorrisonJH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci1987;7(6):1799–1808.
30.
McKeeACAuRCabralHJKowallNWSeshadriSKubilusCA. Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol2006;65(6):621–30 doi: 10.1097/00005072-200606000-00010.
31.
YinHChenLChenXLiuX. Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma. Med Hypotheses2008;71(7):77–80 doi: 10.1016/j.mehy.2008.01.030.
32.
YonedaSHaraHHirataAFukushimaMInomataYTaniharaH. Vitreous fluid levels of beta-amyloid((1–42)) and tau in patients with retinal diseases. Jpn J Ophthalmol2005;49(2):106–8 doi: 10.1007/s10384-004-0156-x.
33.
JanciauskieneSKrakauT. Alzheimer's peptide: A possible link between glaucoma, exfoliation syndrome and Alzheimer's Disease. Acta Ophthalmol Scand2001;79(3):328–9 doi: 10.1034/j.1600-0420.2001.790327.x.
34.
GuptNFongJAngLCYucelYH. Retinal tau pathology in human glaucomas. Can J Ophthalmol2008;43(1):53–60 doi: 10.3129/i07-185.
35.
GuoLSaltTELuongVWoodNCheungWMaassA. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A2007;104(33):13444–9 doi: 10.1073/pnas.0703707104.
36.
CalkinsDJ. A neurological perspective on glaucoma. Glaucoma Today2008 Sep-Oct:18–20.
37.
BuckinghamBPInmanDMLambertWOglesbyECalkinsDJSteeleMR. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci2008;28(11):2735–44 doi: 10.1523/jneurosci.4443-07.2008.
38.
WilliamsPAThirgoodRAOliphantHFrizzatiALittlewoodEVotrubaM. Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease. Neurobiol Aging2013;34(7):1799–1806 doi: 10.1016/j.neurobiolaging.2013.01.006.
39.
TsaiCSRitchRSchwartzBLeeSSMillerNRChiT. Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol1991;109(2):199–204 doi: 10.1001/archopht.1991.01080020045040.
40.
TrickGLCalottiFYSkarfB. Advances in imaging of the optic disc and retinal nerve fiber layer. J Neuroophthalmol2006;26(4):284–95 doi: 10.1097/01.wno.0000249327.65227.67.
41.
FujimotoJG. Optical coherence tomography. C R Acad Sci. Ser IV2001;2:1099–1111 doi: 10.1016/S1296-2147(01)01257-4.
42.
SakataLMDeleon-OrtegaJSakataVGirkinCA. Optical coherence tomography of the retina and optic nerve — a review. Clin Experiment Ophthalmol2009;37(1):90–9 doi: 10.1111/j.1442-9071.2009.02015.x.
43.
IseriPKAltinasOTokayTYukselN. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol2006;26(11):18–24 doi: 10.1097/01.wno.0000204645.56873.26.
44.
PaquetCBoissonnotMRogerFDighieroPGilRHugonJ. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett2007;420(2):97–9 doi: 10.1016/j.neulet.2007.02.090.
45.
LuYLiZZhangXMingB. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography. Neurosci Lett2010;480(1):69–72 doi: 10.1016/j.neulet.2010.06.006.
46.
KeslerAVakhapovaVKorczynADNaftalievENeudorferM. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg2011;113(7):523–6 doi: 10.1016/j.clineuro.2011.02.014.
47.
Danesh-MeyerHVBirchHKuJYCarrollSGambleG. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology2006;67(10):1852–4 doi: 10.1212/01.wnl.0000244490.07925.8b.
48.
KergoatHKergoatMJJustinoLChertkowHRobillardABergmanH. An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol Scand2001;79(2):187–91 doi: 10.1034/j.1600–0420.2001.079002187.x.
49.
LeveyALahJGoldsteinFSteenlandKBliwiseD. Mild cognitive impairment: An opportunity to identify patients at high risk for progression to Alzheimer's disease. Clin Ther2006;28(7):991–1001 doi: 10.1016/j.clinthera.2006.07.006.
YaqoobZWuJYangC. Spectral domain optical coherence tomography: A better OCT imaging strategy. Biotechniques2005;39(6 Suppl):S6–13 doi: 10.2144/000112090.
52.
ChomaMSarunicMYangCIzattJ. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express2003;11(18):2183–9 doi: 10.1364/OE.11.002183.
53.
NassifNCanseBParkBHYunSHChenTCBoumaBE. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett2004;29(5):480–2 doi: 10.1364/OL.29.000480.
GabrieleMLIshikawaHWollsteinGBilonickRAKagemannLWojtkowskiM. Peripapillary nerve fiber layer thickness profile determined with high speed, ultrahigh resolution optical coherence tomography high-density scanning. Invest Ophthalmol Vis Sci2007;48(7):3154–60 doi: 10.1167/iovs.06-1416.
56.
KirbasSTurkyilmazKAnlarOTufekciADurmusM. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol2013;33(1):58–61 doi: 10.1097/WNO.0b013e318267fd5f.
57.
MarzianiEPonatiSRamolfoPCigadaMGianiAMarianiC. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci2013;54(9):5953–8 doi: 10.1167/iovs.13-12046.
58.
AakerGDMyungJSEhrlichJRMohammedMHenchcliffeCKissS. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol2010;4:1427–32 doi: 10.2147/OPTH.S15136.
59.
AdamCRShrierEDingYGlazmanSBodis-WollnerI. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol2013;33(2):137–42 doi: 10.1097/WNO.0b013e31828c4e1a.
60.
Garcia-MartinESatueMFuertesIOtinSAlarciaRHerreroR. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology2012;119(10):2161–7 doi: 10.1016/j.ophtha.2012.05.003.
61.
KhanifarAAParlitsisGJEhrlichJRAakerGDD'AmicoDJGauthierSA. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol2010;4:1007–13 doi: 10.2147/OPTH.S13278.
62.
YasunoYMadjarovaVDMakitaSAkibaMMorosawaAChongC. Three-dimensional and high-speed swept-source optical coherence tomography for in vivo investigation of human anterior eye segments. Opt Express2005;13(26):10652–64 doi: 10.1364/OPEX.13.010652.
63.
PelakVS. Ocular motility of aging and dementia. Curr Neurol Neurosci Rep2010;10(6):440–7 doi: 10.1007/s11910-010-0137-z.
64.
WangJHathawayMShidlovskiVDaintyCPodoleanuA. Evaluation of the signal noise ratio enhancement of SS-OCT versus TD-OCT using a full field interferometer. In: FujimotoJGIzattJATuchinVV, editors. Proceedings of SPIE 7168, Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XIII; 2009 Jan 26–28; San Jose, CA. Bellingham (WA): SPIE c2009. p. 71682K doi: 10.1117/12.809043.
65.
ChomaMAHsuKIzattJA. Swept source optical coherence tomography using an all-fiber 1300-nm ring laser source. J Biomed Opt2005;10(4):44009 doi: 10.1117/1.1961474.
66.
PotsaidBBaumannBHuangDBarrySCableAESchumanJS. Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express2010;18(19):20029–48 doi: 10.1364/oe.18.020029.
67.
EsmaeelpourMPovazayBHermannBHoferBKajicVKapoorK. Three-dimensional 1060-nm OCT: Choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci2010;51(10):5260–6 doi: 10.1167/iovs.10-5196.
68.
YasunoYMiuraMKawanaKMakitaSSatoMOkamotoF. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by highpenetration optical coherence tomography. Invest Ophthalmol Vis Sci2009;50(1):405–13 doi: 10.1167/iovs.08-2272.
69.
de BruinDMBurnesDLLoewensteinJChenYChangSChenTC. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm. Invest Ophthalmol Vis Sci2008;49(10):4545–52 doi: 10.1167/iovs.07-1553.
70.
YasunoYHoangYMakitaSYamanamiNAkibaMMiuraM. In vivo high-contrast imaging of deep posterior eye by 1-μm swept source optical coherence tomography and scattering optical coherence angiography. Opt Express2007;15(10):6121–39 doi: 10.1364/OE.15.006121.
71.
MillerDTKocaogluOPWangQLeeS. Adaptive optics and the eye (super resolution OCT). Eye2011;25(3):321–30 doi: 10.1038/eye.2011.1.
